India, June 28 -- The obsession with weight loss injections is still going strong. After the social media frenzy around Ozempic last year and celebrities such as Meghan Trainor, Lizzo, and Amy Schumer admitting to using it, and the buzz when Mounjaro (Elon Musk revealed he used it too!) arrived in India this March, there's a new contender on the block: Wegovy. Earlier this week (June 24), Danish pharmaceutical giant Novo Nordisk launched this much-anticipated drug in India. But what makes it different from its predecessors, and why is everyone talking about it? Wegovy is designed for long-term weight management and to help reduce the risk of serious cardiovascular events in people living with obesity. It comes in a sleek, once-weekly pen ...